Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
WJET Erie on MSN3d
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billion
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
Zantac maker GSK agrees to pay $2.3 bn in US settlements
British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to ...
pharmaphorum3d
GSK says $2.2bn settlement resolves most Zantac litigation
GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...
Pharmaceutical company GSK agrees to pay $2.3 bn in US settlements alleging Zantac cancer claims
British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to ...
Barron's4d
Zantac Maker GSK Agrees To Pay $2.3 Bn In US Settlements
The over-the-counter treatment, known also by its non-commercial name ranitidine, was manufactured by several rivals including the French group Sanofi and US drugmaker Pfizer before it was ...
Law23d
Another Mistrial in Zantac: Fourth Illinois Jury Fails to Award Damages
A fourth Chicago jury failed to award damages to cancer victims suing a manufacturer of over-the-counter heartburn medication Zantac, but the first trial in California is ramping up. On Wednesday ...